Topic - European Commission

The commission said the pharmaceutical firm “misused the patent system to artificially extend patent protection” for its blockbuster MS drug Copaxone, whose active ingredient is glatiramer acetate.

EU Commission fines Teva $500 million for attempting to stop rival's multiple sclerosis drug →

commission says companies in China accomplished that with the help of subsidies all along the chain of production, from cheap land for factories from local governments to below-market supplies of lithium and batteries from state-owned enterprises to tax breaks and below-interest financing from state-controlled banks.

What to know about EU's tariffs on Chinese electric vehicles →